MEVACOR

Mevacor Adverse Events Reported to the FDA Over Time

How are Mevacor adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Mevacor, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Mevacor is flagged as the suspect drug causing the adverse event.

Most Common Mevacor Adverse Events Reported to the FDA

What are the most common Mevacor adverse events reported to the FDA?

Myalgia	30 (3.9%)
Rhabdomyolysis	27 (3.51%)
Drug Interaction	24 (3.12%)
Completed Suicide	19 (2.47%)
Muscle Spasms	17 (2.21%)
Pain In Extremity	17 (2.21%)
Muscular Weakness	13 (1.69%)
Asthenia	12 (1.56%)
Headache	12 (1.56%)
Alanine Aminotransferase Increased	11 (1.43%)
Fall	11 (1.43%)
	Show More
Fatigue	11 (1.43%)
Aspartate Aminotransferase Increase...	10 (1.3%)
Drug Ineffective	9 (1.17%)
Blood Creatine Phosphokinase Increa...	8 (1.04%)
Pain	8 (1.04%)
Back Pain	7 (.91%)
Disturbance In Attention	7 (.91%)
Influenza Like Illness	7 (.91%)
Nausea	7 (.91%)
Renal Failure Acute	7 (.91%)
Abdominal Pain Upper	6 (.78%)
Amyotrophic Lateral Sclerosis	6 (.78%)
Depression	6 (.78%)
Diarrhoea	6 (.78%)
Insomnia	6 (.78%)
Malaise	6 (.78%)
Nervous System Disorder	6 (.78%)
Overdose	6 (.78%)
Anxiety	5 (.65%)
Arthralgia	5 (.65%)
Dizziness	5 (.65%)
Feeling Abnormal	5 (.65%)
Gait Disturbance	5 (.65%)
Movement Disorder	5 (.65%)
Muscle Injury	5 (.65%)
Myocardial Infarction	5 (.65%)
Myopathy	5 (.65%)
Thinking Abnormal	5 (.65%)
Urinary Tract Infection	5 (.65%)
Weight Decreased	5 (.65%)
Adverse Event	4 (.52%)
Arthropathy	4 (.52%)
Balance Disorder	4 (.52%)
Blood Cholesterol Increased	4 (.52%)
Bone Marrow Disorder	4 (.52%)
Constipation	4 (.52%)
Drug Dose Omission	4 (.52%)
Dyspnoea	4 (.52%)
Dysstasia	4 (.52%)
Hot Flush	4 (.52%)
Palpitations	4 (.52%)
Abasia	3 (.39%)
Alopecia	3 (.39%)
Anorexia	3 (.39%)
Bradyarrhythmia	3 (.39%)
Burning Sensation	3 (.39%)
Chest Pain	3 (.39%)
Circulatory Collapse	3 (.39%)
Convulsion	3 (.39%)
Drug Administration Error	3 (.39%)
Drug Intolerance	3 (.39%)
Drug Toxicity	3 (.39%)
Foot Fracture	3 (.39%)
Hepatitis	3 (.39%)
Hyperkalaemia	3 (.39%)
Hypersensitivity	3 (.39%)
Hypertension	3 (.39%)
Hypokalaemia	3 (.39%)
Liver Function Test Abnormal	3 (.39%)
Memory Impairment	3 (.39%)
Musculoskeletal Stiffness	3 (.39%)
Nervousness	3 (.39%)
Papilloedema	3 (.39%)
Paraesthesia	3 (.39%)
Tachycardia	3 (.39%)
Tremor	3 (.39%)
Vomiting	3 (.39%)
Weight Increased	3 (.39%)
Wrong Technique In Drug Usage Proce...	3 (.39%)
Blindness Unilateral	2 (.26%)
Blood Alkaline Phosphatase Increase...	2 (.26%)
Blood Bilirubin Increased	2 (.26%)
Blood Pressure Decreased	2 (.26%)
Bone Marrow Transplant	2 (.26%)
Bradycardia	2 (.26%)
Cardiac Arrest	2 (.26%)
Cataract	2 (.26%)
Cerebral Disorder	2 (.26%)
Cerebral Haemorrhage	2 (.26%)
Cerebrovascular Accident	2 (.26%)
Cerebrovascular Disorder	2 (.26%)
Condition Aggravated	2 (.26%)
Coordination Abnormal	2 (.26%)
Deep Vein Thrombosis	2 (.26%)
Diplopia	2 (.26%)
Dysarthria	2 (.26%)
Erectile Dysfunction	2 (.26%)
Erythema	2 (.26%)
Fungal Infection	2 (.26%)
Gallbladder Disorder	2 (.26%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Mevacor, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Mevacor is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Mevacor

What are the most common Mevacor adverse events reported to the FDA?

Muscle	102 (13.26%)
Therapeutic And Nontherapeutic Effe...	41 (5.33%)
Neurological	36 (4.68%)
Musculoskeletal And Connective Tiss...	34 (4.42%)
Hepatobiliary	28 (3.64%)
Gastrointestinal Signs	21 (2.73%)
Suicidal And Self-injurious Behavio...	21 (2.73%)
Medication Errors	18 (2.34%)
Injuries	16 (2.08%)
Mental Impairment	14 (1.82%)
Joint	13 (1.69%)
	Show More
Renal Disorders	13 (1.69%)
Gastrointestinal Motility And Defec...	12 (1.56%)
Headaches	12 (1.56%)
Neuromuscular	12 (1.56%)
Hepatic And Hepatobiliary	11 (1.43%)
Movement Disorders	11 (1.43%)
Anxiety Disorders	10 (1.3%)
Cardiac Arrhythmias	10 (1.3%)
Enzyme	10 (1.3%)
Physical Examination Topics	9 (1.17%)
Vision	9 (1.17%)
Coronary Artery	8 (1.04%)
Hematology Investigations	8 (1.04%)
Infections - Pathogen Unspecified	8 (1.04%)
Respiratory	8 (1.04%)
Sleep Disorders	8 (1.04%)
Electrolyte And Fluid Balance Condi...	7 (.91%)
Lifestyle Issues	7 (.91%)
Central Nervous System Vascular	6 (.78%)
Chemical Injury And Poisoning	6 (.78%)
Depressed Mood Disorders	6 (.78%)
Disturbances In Thinking	6 (.78%)
Epidermal And Dermal Conditions	6 (.78%)
Lipid Analyses	6 (.78%)
Bone And Joint Injuries	5 (.65%)
Cardiac And Vascular Investigations	5 (.65%)
Decreased And Nonspecific Blood Pre...	5 (.65%)
Vascular	5 (.65%)
Allergic Conditions	4 (.52%)
Cardiac Disorder Signs	4 (.52%)
Connective Tissue Disorders	4 (.52%)
Embolism And Thrombosis	4 (.52%)
Hematological	4 (.52%)
Skin Appendage Conditions	4 (.52%)
Urinary Tract Signs	4 (.52%)
Appetite And General Nutritional	3 (.39%)
Gallbladder	3 (.39%)
Hematological And Lymphoid Tissue T...	3 (.39%)
Ocular Structural Change, Deposit A...	3 (.39%)
Peripheral Neuropathies	3 (.39%)
Renal And Urinary Tract Investigati...	3 (.39%)
Seizures	3 (.39%)
Vascular Hypertensive	3 (.39%)
Anterior Eye Structural Change, Dep...	2 (.26%)
Body Temperature Conditions	2 (.26%)
Developmental	2 (.26%)
Economic And Housing Issues	2 (.26%)
Exocrine Pancreas Conditions	2 (.26%)
Fungal Infectious	2 (.26%)
Gastrointestinal Conditions	2 (.26%)
Gastrointestinal Hemorrhages	2 (.26%)
Glaucoma And Ocular Hypertension	2 (.26%)
Heart Failures	2 (.26%)
Hemolyses And Related Conditions	2 (.26%)
Immune	2 (.26%)
Musculoskeletal And Soft Tissue Inv...	2 (.26%)
Nephropathies	2 (.26%)
Nervous System, Skull And Spine The...	2 (.26%)
Ocular Hemorrhages And Vascular	2 (.26%)
Oral Soft Tissue Conditions	2 (.26%)
Sexual Function And Fertility	2 (.26%)
Vascular Hemorrhagic	2 (.26%)
Viral Infectious	2 (.26%)
Anemias Nonhemolytic And Marrow Dep...	1 (.13%)
Arteriosclerosis, Stenosis, Vascula...	1 (.13%)
Aural	1 (.13%)
Autoimmune	1 (.13%)
Bladder And Bladder Neck Disorders	1 (.13%)
Cardiac And Vascular Disorders Cong...	1 (.13%)
Changes In Physical Activity	1 (.13%)
Deliria	1 (.13%)
Endocrine Investigations	1 (.13%)
Eye	1 (.13%)
Family Issues	1 (.13%)
Fatal Outcomes	1 (.13%)
Gastrointestinal	1 (.13%)
Gastrointestinal Inflammatory Condi...	1 (.13%)
Glucose Metabolism Disorders	1 (.13%)
Hearing	1 (.13%)
Inner Ear And Viiith Cranial Nerve	1 (.13%)
Investigations, Imaging And Histopa...	1 (.13%)
Lower Respiratory Tract Disorders	1 (.13%)
Mood Disorders	1 (.13%)
Myocardial	1 (.13%)
Ocular Infections, Irritations And ...	1 (.13%)
Pericardial	1 (.13%)
Personality Disorders	1 (.13%)
Pleural	1 (.13%)
Procedural And Device Related Injur...	1 (.13%)
Prostatic Disorders	1 (.13%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Mevacor, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Mevacor is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.